CDNA stock forecast
Our latest prediction for CareDx, Inc.'s stock price was made on the Jan. 15, 2020 when the stock price was at 23.06$.
In the short term (2weeks), CDNA's stock price should underperform the market by -5.25%. During that period the price should oscillate between -9.52% and +8.11%.
In the medium term (3months), CDNA's stock price should underperform the market by -11.51%. During that period the price should oscillate between -32.70% and +19.00%.Get email alerts
About CareDx, Inc.
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
At the moment the company generates 115M USD in revenues.
On its last earning announcement, the company reported a loss of -0.46$ per share.
The book value per share is 0.80$
Three months stock forecastJan. 15, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|